In contrast to the large number of class I and II cytokine receptors, only four Janus kinase (Jak) proteins are expressed in mammalian cells, implying the shared use of these kinases by many different receptor complexes. Consequently, if receptor numbers exceed the amount of available Jak, cross-interference patterns can be expected. We have engineered two model cellular systems expressing two different exogenous Tyk2-interacting receptors. A receptor chimera was generated wherein the extracellular part of the interferon type 1 receptor (Ifnar1) component of the interferon-␣/␤ receptor is replaced by the equivalent domain of the erythropoietin receptor. Despite Tyk2 activation, erythropoietin treatment of cells expressing this erythropoietin receptor/Ifnar1 chimera did not evoke any detectable IFN-type response. However, a dose-dependent interference with signal transduction via the endogenous Ifnar complex was found for STAT1, STAT2, STAT3, Tyk2, and Jak1 activation, for gene induction, and for antiviral activity. In a similar approach, cells expressing the ␤1 chain of the interleukin-12 receptor showed a reduced transcriptional response to IFN-␣ as well as reduced STAT and kinase activation. In both model systems, titration of the Tyk2 kinase away from the Ifnar1 receptor chain accounts for the observed cross-interference.
Members of the class I and class II cytokine receptor families are expressed on the cell surface of virtually all cell types in higher vertebrates. These receptors and their ligands are part of the complex intercellular communication network regulating essential functions, including host defense, hematopoiesis, and metabolism. The cytokine receptor subunits are composed of an extracellular ligand-binding domain containing evolutionarily conserved receptor module(s), one transmembrane domain, and a cytoplasmic region (1, 2) . The mode of receptor complex formation is very heterogeneous and can be either homomeric or heteromeric. Examples of the former are the receptors for erythropoietin (Epo), 1 growth hormone, and leptin. Alternatively, ligands may induce the assembly of heteromeric receptor complexes, which are often characterized by the use of shared components: ␤c for the IL-3/IL-5/granulocyte macrophage-colony-stimulating factor group and ␥c or gp130 for the IL-2 and IL-6 families, respectively (3) . More complex patterns of receptor clustering have also been reported, though there is no evidence so far for receptor complexes composed of both class I and class II subunits. Cytokine receptors lack intrinsic kinase activity, but the ligand-induced clustering or reorganization of the subunits leads to trans-phosphorylation and activation of the associated tyrosine kinases of the Jak family (4, 5) . These latter kinases phosphorylate tyrosine residues in the receptor tails, allowing recruitment and activation of signaling molecules. Among these, STATs (signal transducers and activators of transcription) play an essential role in the transmission of signals to the nucleus (6) .
Class I and class II cytokine receptors emerged in evolution after the tyrosine kinase receptors, as is apparent from the analysis of the Caenorhabditis elegans genome (7) . Interestingly, this receptor family showed a very rapid expansion during recent evolution. To date, over 40 distinct members have been described. The rapid growth of this gene family was, however, not accompanied by a parallel expansion of the Jak family. In fact, only four Jaks (Jak1, Jak2, Jak3, and Tyk2) have been found in mammals and in fish (8) , and a single Jak protein, the product of the Hopscotch gene, appears to exist in the fruit fly Drosophila melanogaster. This is in line with the proposed tetraploidization events during early vertebrate development: two successive chromosome duplications giving rise to four gene copies derived from the single ancestral jak gene. Also, in line with this markedly different evolutionary pattern, a higher degree of sequence conservation is observed for the Jaks as compared with the class I and II cytokine receptors. Consequently, different cytokine receptor complexes utilize common Jak family members. This is true not only for receptor complexes with shared subunits but also for different receptor systems belonging to the class I and class II families. Studies of Jak-deficient cell lines and Jak knock-out mice have demonstrated the dedicated and non-redundant role of each Jak protein in specific cytokine signaling pathways (reviewed in Ref. 4 ). Despite intensive efforts, the structural determinants and the molecular forces governing the specificity of the Jak/receptor interaction remain still to be defined. Whether other signaling, chaperone, or scaffolding molecules sustain such complexes, modulate the affinity, or regulate the partitioning of the kinases among receptors is not known. The shared use of Jak proteins, which are physically associated to diverse receptors, could lead to cross-competition and interfere with downstream signaling. Thus, the central notion of Jak sharing in cytokine signaling predicts that, under certain circumstances, receptor complexes converging onto the same Jak protein could compete with each other. This competition could be evoked if, for example, the local supply of available Jak becomes limiting following up-regulation of a cognate receptor subunit.
To investigate whether cross-competition among receptors can occur, we focused on two heterodimeric cytokine receptor systems that associate with and require the Tyk2 kinase for signal transmission. One is the interferon (IFN)-␣/␤ receptor, which is composed of two class II chains: Ifnar1 and Ifnar2c (also referred to as IFNaR2-2) (9). The other is the interleukin-12 receptor (IL-12R), composed of two class I chains: ␤1 and ␤2, which are finely regulated during T helper cell differentiation (10) . Each of these four receptor chains interacts with a Jak protein. Indeed, both Ifnar1 and ␤1 interact with Tyk2 via their cytoplasmic domains (11) (12) (13) . We studied potential interference on the function of the endogenous IFN-␣/␤ receptor in cells overexpressing an EpoR/Ifnar1 chimera in which the Ifnar1 ectodomain is replaced by the ectodomain of the EpoR. We extended the analysis to cells expressing the IL-12R␤1 chain. By monitoring the IFN-␣2-and the IFN-␤-induced signaling events and biological effects in these model cellular systems, we demonstrate that regardless of ligand engagement by these exogenous receptors, the IFN-␣ signaling circuitry via the endogenous IFN receptors is impaired. We provide evidence supporting a mechanism whereby the exogenous Tyk2-interacting receptor can sequester and titer out the kinase away from the endogenous Ifnar1 receptor chain, corrupting its normal functioning.
EXPERIMENTAL PROCEDURES
Cell lines, Reagents, and Plasmids-Human fibrosarcoma 2fTGH, 11,1 (14) , U5A, and HL116 (15) cells were cultured in Dulbecco's modified Eagle's medium with 10% fetal calf serum at 37°C in 10% CO 2 . Recombinant human Epo was obtained from Amgen (Thousand Oaks, CA). IFN-␣2 was purchased from PeproTech inc. (Rocky Hill, NJ) or was a gift of Dr. Adolf (Roche Molecular Biochemicals), IFN-␤ was a gift of P. Hochman (Biogen Inc.), and IL-12 was a gift of U. Gubler. For the construction of the pSV-SPORT EpoR/Ifnar receptor chimeras, we refer to Ref. 16 . The BS/IL-12R␤1 plasmid and the pEF-BOS expression vector containing the IL-12R␤2 cDNA (17) were gifts of U. Gubler. A XbaI fragment containing the human IL-12R␤1 cDNA was released from pBluescript and cloned into the pSR␣-puro expression vector. Plasmid pRc-Tyk2 is described in Ref. 18 .
Transfections and Development of Stable Cell Lines-For the development of stable cell lines expressing the EpoR/Ifnar1 chimera, 2fTGH cells were transfected with 20 g of pSV-SPORT-EpoR/Ifnar1 and 2 g of vector pcDNA1/Neo. Single neo R colonies were screened for EpoR/ Ifnar1 expression by RT-PCR (16 Immunoprecipitation and Western Blot Analysis-Cells were treated for 15 min (for detection of Jak kinases) or 30 min (for STATs) with increasing doses of Epo, IFN-␣2, or IFN-␤ (ranging from 1 pM to 1 nM) and lysed in a buffer containing 50 mmol/liter Tris-HCl, pH 8, 200 mmol/liter NaCl, 2 mmol/liter EDTA, 0.5% sodium deoxycholate, 1% Nonidet P-40, 0.05% SDS, 2 mmol/liter Pefablock (Merck KgaA, Darmstadt, Germany), 2 mmol/liter sodium orthovanadate, 30 g/ml aprotinin, and 30 g/ml leupeptin. Clarified lysates were immunoprecipitated with R5-7 Tyk2 antiserum (20) or with Jak1 M7 antiserum (a gift of A. Ziemiecki) and analyzed by immunoblotting with the anti-phosphotyrosine 4G10 mAB (Upstate Biotechnology, Inc.), the anti-Tyk2 T10 -2 mAb (21), or the anti-Jak1 M7. Tyrosine phosphorylated STAT1, STAT2, and STAT3 were detected by immunoblotting with phosphospecific antibodies and, after stripping, with the specific STAT antibodies to evaluate loading. Anti-phospho-STAT1 and -STAT3 antibodies were from New England Biolabs, anti-phospho-STAT2 was a gift from D. Levy, anti-STAT1 and anti-STAT2 were from New England Biolabs and Upstate Biotechnology, and anti-STAT3 was from Santa Cruz Biotechnologies.
Luciferase Activity Measurement-To measure luciferase activity, cells were treated for 6 h with increasing doses of IFN-␣2 and IFN-␤ ranging from 1 to 100 pM. Cells were lysed, and the luciferase activity was quantified in a luminometer (EG&E Berthold) as described in Ref. 15 . The activity in cells stimulated with an excess of IFN (1.5 nM) was considered as 100% and that in untreated cells was considered as 0% activity. Statistical analysis for the comparison of mean doses inducing 50% luciferase activity in transfected clones with the mean doses inducing 50% activity in HL116 cells was carried out with the use of t tests according to Ref. 22 .
FACS Analysis-Surface IL-12R␤1 and -␤2 expression was monitored by staining cells with 5 g/ml purified rat anti-huIL-12R␤1 mAb (2B10) (23) and with 10 g/ml rat anti-huIL-12R␤2 mAb (2B6) (24) . Both antibodies were gifts of U. Gubler. After washing in phosphatebuffered saline, 3% serum, cells were incubated with 10 g/ml biotinylated polyclonal anti-rat IgG antibody (Jackson ImmunoResearch Laboratories, West Grove, PA) and with streptavidin-phycoerythrin (Jackson ImmunoResearch Laboratories). In Fig. 7A , surface Ifnar1 levels were analyzed by incubating cells with 5 g/ml EA12-AF4 mAb followed by staining with 3 g/ml R-phycoerythrin goat anti-mouse IgG (Molecular Probes). In B, Tyk2 phosphorylation in response to Epo. 2fTGH, EpoR/Ifnar1cl.12, and EpoR/Ifnar1cl.6 cells were treated for 15 min with increasing doses of Epo. Tyk2 was immunoprecipitated from cell lysates and resolved on 7% SDS-polyacrylamide gel. Tyrosine phosphorylation was revealed with the phosphotyrosine-specific 4G10 mAb. The membrane was stripped and reprobed with a Tyk2-specific mAb.
bating cells with 10 g/ml AA3 mAb followed by incubation with 10 g/ml biotinylated anti-mouse IgG antibody and streptavidin-phycoerythrin. Anti-human Ifnar1 mAbs were a gift of L. Runkel (25) . The anti-human Ifnar2 mAb (MMHAR-2) was purchased from PBL (Biochemical Laboratories). Cells were analyzed with a FACScan flow cytometer (Becton-Dickinson).
Quantitative RT-PCR-Total RNA from IFN-treated cells was purified using the High Pure RNA Isolation Kit from Roche Diagnostics GmbH. Reverse transcriptions were primed with oligo(dT) and performed using the MuLv Reverse Transcriptase from Life Technologies, Inc. Quantitative PCR assays were done using the SYBR Green I technology on a LightCycler (Roche Diagnostics GmbH). The primer pairs used were: GAPDH forward: 5Ј-ACAGTCCATGCCATCACTGCC-3Ј, reverse: 5Ј-GCCTGCTTCACCACCTTCTTG-3Ј; 6-16 forward: 5Ј-CATGCGGCAGAAGGCGGTAT-3Ј, reverse: 5Ј-CGACGGCCATGAAG-GTCAGG-3Ј; and 2Ј-5Ј-oligoadenylate synthetase (69 kDa) forward: 5Ј-AACTGCTTCCGACAATCAAC-3Ј, reverse: CCTCCTTCTCCCTC-CAAAA-3Ј. Quantification standard curves were obtained using PCR products diluted in 10 g/ml sonicated salmon sperm DNA. The specificity of PCR products was checked by melting curve analysis and DNA sequencing.
Cell Survival Assays-Cells were treated with increasing doses of IFN-␣2, IFN-␤, or Epo for 16 h. Medium was removed, and cells were challenged with the virus at a multiplicity of infection of 1. The cytopathic effect was scored 20 h after infection by staining living cells with a crystal violet solution (0.5% crystal violet (w/v), 3% formaldehyde, 30% ethanol, and 0.17% NaCl (w/v)). Staining was quantified by solubilizing in 30% acidic acid and measured in an enzyme-linked immunosorbent assay reader (Dynatech Laboratories Inc., Chantilly, VA) at 590 nm. All experiments were performed in triplicate.
RESULTS

The EpoR/Ifnar1 Chimera Down-modulates the IFN Response
Interference with Antiviral Activity-The extracellular domain of the human EpoR was fused to the transmembrane and intracellular regions of the human Ifnar1 receptor subunit (Fig.  1A) . Stable 2fTGH clones expressing the EpoR/Ifnar1 receptor were selected. The expression level of the chimeric receptor in different clones was determined by Scatchard plot analysis using iodinated Epo. Two clones were chosen for further studies: the EpoR/Ifnar1 cl.6 and cl.12, expressing 35,000 and 3,500 chimeric receptors, respectively, on their cell surface. To assess whether the chimeric receptor, in addition to binding the ligand, was also competent to interact with Tyk2, we measured Tyk2 phosphorylation in response to Epo. As shown in Fig. 1B , inducible phosphorylation of Tyk2 could be detected in cl.6. This result indicates that the Ifnar1 portion of the chimeric receptor recruits Tyk2 and suggests that the Epo-driven dimerization of the chimera may occur through a mechanism similar to the allosteric reorganization of the wild type EpoR that allows activation of the associated Jak (26) .
Despite Tyk2 activation, Epo treatment of cells expressing the EpoR/Ifnar1 receptor did not evoke any detectable IFNtype response. In a cell survival assay, up to 100 pM Epo failed to lower the cytopathic effects of either VSV or EMCV (Fig. 2) . Remarkably, however, the expression of the EpoR/Ifnar1 chimera reduced the survival of IFN-␣2-treated cells challenged with viruses. The extent of this effect correlated with the expression level of the chimeric receptor as it was more pronounced in cl.6 than in cl.12. Protection against VSV infection was more affected than protection against EMCV (Fig. 2) . Conversely, the survival of IFN-␤-treated cells was not significantly altered by the expression of the chimera. These results demonstrate an interference by the chimeric receptor on the antiviral activity of IFN-␣2 via the endogenous IFN receptor complex.
Interference with 6 -16 mRNA Induction-The IFN-␣/␤ tran- scriptional response of 2fTGH cells expressing different levels of EpoR/Ifnar1 was compared by measuring the mRNA levels of two prototypic ISGF3-dependent genes, 6 -16 and the 69-kDa 2Ј-5Ј-oligoadenylate synthetase (27) , by a quantitative RT-PCR approach. The ratios of each mRNA level to the GAPDH mRNA level are represented in Fig. 3 as a function of IFN doses, whereby IFN was added for 6 h to the cells. Cl.6, but not cl.12, showed a clear reduction of sensitivity to IFN-␣2 as compared with the parental 2fTGH cells (Fig. 3, A and C) . Conversely, similar mRNA induction profiles were obtained upon IFN-␤ treatment of the parental 2fTGH and the EpoR/Ifnar1-expressing clones (Fig. 3, B and D) .
The IL-12R␤1 Chain Down-modulates the IFN-␣-induced Transcriptional Activity
Having shown that the overexpression of the cytoplasmic domain of Ifnar1 impairs the IFN response, we set out to analyze the potential effect of another cytokine receptor that interacts with Tyk2, i.e. the ␤1 chain of the IL-12R. We used as a recipient the fibrosarcoma HL116 cells, which contain a luciferase reporter gene under the control of the 6 -16 promoter (15). We derived HL116 clones that stably expressed at their cell surface the human IL-12R␤1, the IL-12R␤2, or both chains. Clones were regularly monitored by FACS analysis to assess maintenance of the exogenous receptor chain(s) (data not shown). The reconstitution of a functional IL-12 receptor in ␤1␤2-expressing clones was confirmed by the detection of a robust Tyk2 phosphorylation in response to as little as 1 ng/ml IL-12 (data not shown).
The IFN-␣2 and the IFN-␤ sensitivity of seven ␤1-expressing clones (HL␤1), three ␤2-expressing clones (HL␤2), five ␤1␤2-expressing clones (HL␤1␤2), and seven control clones (HL) were measured in a luciferase activity assay following a 6-h treatment with increasing doses of IFN-␣2 or IFN-␤ (Fig. 4A,  left panel) . At least five experiments were performed with each clone, using the HL116 cells as wild type standard (see "Experimental Procedures"). Although the IFN-␣2 sensitivity of the ␤2-expressing clones and of the control HL clones was similar to that of HL116 cells, the IFN-␣2 sensitivity of the ␤1-expressing clones or of the ␤1␤2-expressing clones was 2-to-6-fold lower than that of the HL116 cells. On the other hand, the IFN-␤ sensitivity was not significantly down-modulated by the expression of the ␤1 chain (Fig. 4A, right panel) or of both the ␤1 and ␤2 chains (data not shown).
Further analyses were carried out on a control clone (HLcl.3) and a ␤1-expressing clone (HL␤1-cl.6) whose level of surface ␤1 expression is shown in Fig. 7B . The IFN-␣2 and IFN-␤ sensitivities of these cells were compared by measuring the induction of the 6 -16 and 2Ј-5Ј-oligoadenylate synthetase mRNA by quantitative RT-PCR. A reduced response to IFN-␣2 was observed in the ␤1-expressing clone compared with the control clone, whereas the IFN-␤ sensitivity appeared not to be affected (Fig. 4, B and C) .
Both the EpoR/Ifnar1 Chimera and the IL-12R␤1
Interfere with the Jak-STAT Pathway
Having shown that the ectopic expression of the EpoR/Ifnar1 chimera or of the IL-12R␤1 chain interfered with the IFN-␣2-induced transcriptional response, it was of interest to determine whether the activation of Jak/STAT pathway components was concomitantly affected. For this, the level of tyrosine phosphorylation of STAT1, STAT2, and STAT3 was monitored in the clones expressing the EpoR/Ifnar1 chimera with respect to the parental cells (Fig. 5A) . In EpoR/Ifnar1 cl.6 treated with IFN-␣, a marked reduction of phosphorylation of the three STAT proteins was observed. In EpoR/Ifnar1 cl.12, the reduction was less pronounced. Although a reduction of phosphorylation of STAT1 and STAT2 by IFN-␤ was observed in cl.6 and in cl.12 ( Fig. 5A) , the residual activated fraction is likely to account for the normal transcriptional response of these cells to IFN-␤ (see Fig. 3, B and D) . Interestingly, the more drastic reduction was consistently observed for STAT3. A similar analysis was performed with two ␤1-expressing clones and the control clone. As shown in Fig. 6A, STAT3 , STAT1, and to a lesser extent, STAT2 phosphorylation was reduced in the ␤1 clones treated with IFN-␣. The reduction was most evident in HL␤1-cl.6 (at 100 pM IFN-␣, 5-fold and 2-fold reduction for STAT1 and STAT2, respectively). Conversely, in Membranes were probed with anti-phospho-STAT antibodies as indicated on the left side. Membranes were stripped and reprobed with the specific STAT antibody to verify loading. B, tyrosine phosphorylation level of Tyk2 and Jak1 in cells expressing EpoR/Ifnar1. Tyk2 and Jak1 were immunoprecipitated from clarified lysates of cells treated as indicated above. Tyrosine phosphorylation was revealed using the phosphotyrosine-specific 4G10 mAb. Membranes were stripped and reprobed with Tyk2-and Jak1-specific antibodies to verify loading. cells treated with IFN-␤, the only consistent reduction in phosphorylation was observed for STAT3. Altogether, these results demonstrate that in the presence of either the Epo/Ifnar1 chimera or the IL-12R␤1 chain, the IFN-␣ signaling pathway is less competent as a result of interference at the level of STAT activation.
Next, we analyzed the extent of Tyk2 and Jak1 activation by IFN-␣ in cells expressing the exogenous receptors. In EpoR/ Ifnar1 clones, a dose-dependent reduction of Tyk2 and Jak1 phosphorylation was observed with respect to 2fTGH cells. Consistently, the effect was more marked for cl.6 (Fig. 5B) . Similar results were obtained with the IL-12R␤1-expressing clones compared with the control clone (Fig. 6B) . Interestingly, the non-induced level of phosphorylated Tyk2 was augmented in ␤1-expressing cells, most likely as a consequence of its constitutive association with the IL-12R␤1 chain. These results demonstrate that the interference observed is due to a reduced level of activation of the Jak kinases associated with the IFN receptor.
Both the EpoR/Ifnar1 Chimera and the IL-12R␤1 Reduce the Level of the Endogenous Ifnar1
In human cells, Tyk2 has been shown to contribute to IFN-␣ signaling not only as a tyrosine kinase but also as an intrinsic component of the IFN-␣ receptor complex involved in sustaining the level of Ifnar1 and ensuring the high affinity binding of IFN-␣ (18, 28) . On this basis, we asked whether the presence of the EpoR/Ifnar1 chimera or of the IL-12R␤1 (via their interaction with Tyk2) could affect the level of the endogenous Ifnar1 protein. Indeed, FACS analysis showed a reduced surface Ifnar1 level in the EpoR/Ifnar1 cl.6 with respect to the EpoR/ Ifnar1 cl.12 and the parental cells, whereas the Ifnar2 levels were unchanged (Fig. 7A) . Ifnar1 surface levels were also analyzed in the two ␤1-expressing clones and the control clone. An average 2-fold reduction of Ifnar1 was detected in the ␤1-expressing clones as compared with the control clone. Ifnar1 staining was higher in the control clone (HL-cl.3 in Fig. 7B ) as compared with 2fTGH (Fig. 7A) because of the use of a more reactive mAb (25) and a biotin-streptavidin amplification step (see "Experimental Procedures").
Overexpression of Tyk2 Rescues the IFN-␣ Response in an IL-12R␤1-expressing Clone
Since Tyk2 is the only element shared among the endogenous IFN receptor, the Epo/Ifnar1 chimera, and the IL-12R␤1 chain, the observed cross-interference may result from titration of the kinase. To verify this hypothesis, we tested whether stable overexpression of Tyk2 in ␤1-expressing cells (HL␤1-cl.6) could relieve the defect. Two clones, T1 and T6, expressing a 4.5-fold higher Tyk2 level than control C1 and C2 clones (Fig.  8A) , were tested for their IFN-␣ sensitivity and for the level of surface Ifnar1. As shown in Fig. 8B , a significant increase in luciferase inducibility was observed in T1 and T6 with respect to the control clones or to the parental HL116. The level of surface Ifnar1 was increased approximately 2-fold, whereas the level of Ifnar2 was left unchanged (Fig. 8C) . Thus, an increase in the Tyk2 level appears to relieve the impairment of IFN-␣ signaling caused by the presence of the IL-12R␤1 receptor.
DISCUSSION
Integration of signals emanating from cytokine receptors is critical to the coordinate regulation of the complex cytokine network. A number of molecular mechanisms have been described to date. The existence of shared subunits among heteromeric-type receptors represents a major source of crosscompetition between different ligands (3, 29) . Evidence for competition among Jak proteins for common binding sites on the gp130 chain has been provided (30) . The transcriptional induction of the SOCS/SSI/JAB proteins represents another mechanism of cytokine signaling trans-modulation (31) . Here, we have investigated whether interference can occur among cytokine receptors via competition for Jak tyrosine kinases. Our study has focused on the type 1 IFN receptor, which is a complex functional unit of unknown stoichiometry and whose signaling outcome and biological potency vary among cell types and in response to the various ligands. The specific role of each receptor subunit has been extensively studied using a number of approaches (9) . Ifnar1 exerts a positive role in signaling through bringing into the receptor/Jak1 complex its associated Tyk2 protein. Accordingly, Tyk2 was shown to amplify and potentiate signaling initiated by Jak1 (21, 32) . Ifnar1 was (40 g) were resolved by 7% SDSpolyacrylamide gel. Membranes were probed with anti-phospho-STAT antibodies as indicated on the left side. Membranes were stripped and reprobed with the specific STAT antibody to verify loading. B, tyrosine phosphorylation level of Tyk2 and Jak1 in cells expressing IL-12R␤1. Tyk2 and Jak1 were immunoprecipitated from lysates of cells treated as described in panel A. Tyrosine phosphorylation was revealed using the phosphotyrosine-specific 4G10 mAb. Membranes were stripped and reprobed with Tyk2-and Jak1-specific antibodies to verify loading.
found post-translationally up-regulated during the differentiation of human monocytes into macrophages, and this may partly account for the increased antiviral effect of IFN-␣/␤ in differentiated cells (33) . A role for Ifnar1 in signal down-modulation has also been suggested because deletion of its carboxyl end leads to increased IFN responses (34) . On the other hand, its contribution as a molecule recruiting STAT2 through its phosphorylated tyrosine motif(s) has also been reported (35) , and its functional association with the STAT-modifying enzyme PRMT1 has recently been demonstrated (36) . Also, a functional role for Ifnar complexes devoided of Ifnar2 is implied from the antiproliferative stimulus observed in Ifnar2 Ϫ/Ϫ thymocytes upon stimulation with a complex of IFN-␣/␤ and the soluble Ifnar2 isoform (37) . Interestingly, Ifnar1 was found to potentiate the IFN-␥ response through its interaction with Ifngr2 within particular caveolar domains of the membrane and this only in the presence of threshold level of autocrine IFN-␣/␤ (38) .
In our previous study, the specific contribution of the intracellular domains of Ifnar1 and Ifnar2 was analyzed using Epodriven dimerization of chimeric receptors (16) . It was shown that Epo stimulation of the Epo-Ifnar2 chimera expressed in 2fTGH cells leads to efficient induction of IFN-sensitive genes but was extremely inefficient in antiviral protection. This result highlighted the indispensable role of Ifnar1 in the induction of an antiviral state (16) . Here, we show that cells expressing the EpoR/Ifnar1 chimera do not exhibit an Epo-induced antiviral response. However, these receptors are expressed on the cell membrane, and an Epo-dependent phosphorylation of the associated Tyk2 occurs. Importantly, in these cells, we detected an EpoR/Ifnar1 dose-dependent down-modulation of the activity of the endogenous IFN receptor complex(es). Interference was observed at the level of activation of Tyk2, Jak1, and STATs (Fig. 5) , on the induction of interferon-stimulated response element-containing genes (Fig. 3) , and on establishment of an antiviral state in response to IFN-␣2 (Fig. 2) . Protection from VSV proved to be more affected by Tyk2 sequestration than protection from EMCV. It is well known that the effectiveness of the various proteins involved in the multiple antiviral pathways of interferon action differs from virus to virus (39) . Our findings imply that the IFN-based antiviral protection against VSV in human fibrosarcoma cells is more dependent on Ifnar1-mediated signaling than is the case for EMCV, which is in accordance with our previous observations (16) . Down-modulation on IFN-␤-induced signals by Tyk2 sequestration was absent or extremely weak.
Interference with IFN-␣/␤ signaling upon expression of a different Tyk2-interacting receptor was also investigated. Several receptor chains have been shown to interact with Tyk2 (gp130, IL-10R2, and IL-12R␤1), but the study of Tyk2-deficient mice has clearly established the requirement for Tyk2 in the induction of physiological responses to IL-12 and not to IL-6 or IL-10 (40, 41). We therefore measured the IFN-induced transcriptional response in a large panel of IL-12R-positive and -negative clones, and we demonstrated a statistically significant down-modulation of IFN-␣2 sensitivity only in cells expressing the ␤1 chain. Accordingly, a reduced level of activation of signaling molecules was observed. These two data sets point to a cross-talk between the endogenous IFN receptors and either the exogenous EpoR/Ifnar1 chimera or the ␤1 chain, which ultimately interferes with the extent of Jak and STAT activation by IFN-␣. Titration of Tyk2 is involved because an excess of receptors with a homologous (EpoR/Ifnar1) or heterologous (IL-12R␤1) Tyk2 binding site is accompanied by reduced surface Ifnar1 level, which (in line with previous observations on the chaperone function of human Tyk2) is a consequence of Tyk2 deprivation. Confirmation of this model comes from the analysis of two ␤1 clones stably overexpressing Tyk2 that were rescued for Ifnar1 level and IFN-␣ sensitivity (Fig. 8) . Interestingly, the responsiveness of these cells appears to exceed that of the HL116 parental cells, possibly as a consequence of signal amplification due to a higher concentration of the kinase at the membrane.
Although Ifnar1 is indispensable for the binding and activities of IFN-␣, it has been shown that IFN-␤ can form a receptor complex with Ifnar2 alone and that this IFN-␤ receptor complex can sustain gene induction (14, 42) . Thus, if the ratio of Ifnar1 to Ifnar2 varies according to Tyk2 availability, receptor composition and signaling outcomes should be more affected for IFN-␣ than for IFN-␤. This is indeed what is observed in cells expressing Tyk2-interacting receptors. However, primary fibroblasts and macrophages from Tyk2 knock-out mice were reported to display only a modest reduction of their response to murine IFN subtypes (40, 41) . In particular, a decrease in Ifnar1 surface level could not be detected in Tyk2-minus cells, although subtle differences could have gone undetected given the quality of reagents available for detection of the murine receptor. Obviously, we cannot rule out the possibility that the murine system differs from the human one, and an example of such a difference was recently reported for the stat2 gene (43) . In addition, conclusions drawn from one species cannot be simply transposed to another species because the analysis of the IFN genes and their products has suggested that the diversification of these genes occurred independently within different orders during the evolution of the mammals (44). Although our studies have all been performed in human HT-1080-derived clones, we have recent evidence that Tyk2 contributes to Ifnar1 cell surface expression in other cellular systems. 2 The phenomenon described here represents the first example of negative interference among cytokine receptors because of the deprivation of a Jak protein. One question that arises is whether this phenomenon could concern receptor/kinase pairs other than Ifnar1/Tyk2. A negative interference exerted by the Epo/Ifnar2c chimera was observed previously on the weak IFN-␤ induction of the 6 -16 gene in Tyk2-deficient 11,1 cells (see Fig. 3 and Ref. 16 ). Titration of a cytosolic kinase has been invoked as the mechanism underlying competition among the multichain receptors for the Fc portion of the immunoglobulin E (Fc⑀R1) in the presence of peptide ligands of differing affinity (45) . Here, the Lyn initiator tyrosine kinase is sequestered by 2 J. Ragimbeau and S. Pellegrini, unpublished observations. receptor complexes aggregated by an excess of low affinity peptide ligands, leading to kinase deprivation of complexes aggregated by high affinity ligands.
Our results suggest that the supply of Tyk2 available to the IFN receptor can become limiting under certain conditions, i.e. following up-regulation of another Tyk2-interacting receptor. Interestingly, the IL-12 receptor is present on natural killer cells and on activated T cells, as opposed to the IFN receptor, which is expressed on all cell types. Moreover, the expression of the IL-12R is finely regulated (10) . Resting T cells lack functional receptors, but upon stimulation with mitogens or T cell receptor cross-linking, they up-regulate the IL-12R␤1 and -␤2 subunits within a few days. Although the expression of the ␤1 subunit is maintained on both Th1 and Th2 subtypes, ␤2 is expressed only on Th1 cells and is controlled by a strict environmental regulation. In the human system, IFN-␣/␤ can induce the ␤2 chain through STAT4 phosphorylation, thus directly contributing to the differentiation of naïve cells along the Th1 pathway (24, 46) . The interference phenomenon among IFN-␣/␤ and IL-12 receptors that we have described here could participate in the complex network regulating the immunomodulatory functions of IFN-␣/␤ and IL-12. To this regard, it will be interesting to test whether activated T cells with an up-regulated IL-12R␤1 chain are less sensitive to IFN-␣/␤ than their precursor naïve cells.
